Operative considerations in implantation of the Perma-Flow graft.
The Perma-Flow coronary bypass graft (Possis Medical, Inc, Minneapolis, MN) currently is undergoing expanded clinical trial. From November 1992 through June 1994 we have used this artificial conduit in 8 patients without autologous alternatives. These cases allowed the establishment of a technical basis for successful implantation of this graft. All studied coronary anastomoses are patent.
Emery
R W
RW
Minneapolis Heart Institute, Minnesota.
Joyce
L D
LD
Arom
K V
KV
King
R M
RM
Nicoloff
D M
DM
D001011:Aorta / Q000601:surgery*; D001166:Arteriovenous Shunt, Surgical / Q000379:methods*; D001807:Blood Vessel Prosthesis / Q000379:methods*; D002315:Cardiopulmonary Bypass / Q000379:methods*; D005240:Feasibility Studies; D006801:Humans; D014683:Vena Cava, Superior / Q000601:surgery*